I tilfælde, hvor hepatitis (inklusiv hepatocellulær, cholestatisk eller blandet leverskade) er diagnosticeret, bør olanzapin seponeres.
In cases where hepatitis (including hepatocellular, cholestatic or mixed liver injury) has been diagnosed, olanzapine treatment should be discontinued.